Trials / Not Yet Recruiting
Not Yet RecruitingNCT06515977
Texture and Colour Enhancement Imaging in Improving Detection and Miss Rate of Premalignant Lesions
Impact of Texture and Color Enhancement Imaging on Detection and Miss Rate of Premalignant Lesions: A Multicentre, Randomized, Tandem Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,964 (estimated)
- Sponsor
- Changhai Hospital · Academic / Other
- Sex
- All
- Age
- 45 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Texture and Color Enhancement Imaging (TXI) is a newly developed image-enhancing endoscopy technology that has show potential in improving detection of colorectal lesions. This multicenter, randomized, tandem trial is aimed at evaluating whether TXI is superior to WLI endoscopy in terms of diagnosis of premalignant lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | TXI (Group A) | Patients in Group A will undergo colonoscopy with TXI. |
| PROCEDURE | TXI followed by WLI (Group B) | Patients in group B will first undergo colonoscopy with TXI and every polyp found should be removed. Then switch to WLI for a second withdrawal to detect lesions that were not observed the first time. |
| PROCEDURE | WLI (Group C) | Patients in Group C will undergo colonoscopy with WLI. |
| PROCEDURE | WLI followed by TXI (Group D) | Patients in group D will first undergo colonoscopy with WLI and every polyp found should be removed. Then switch to TXI for a second withdrawal to detect lesions that were not observed the first time. |
Timeline
- Start date
- 2024-08-01
- Primary completion
- 2025-08-01
- Completion
- 2025-08-01
- First posted
- 2024-07-23
- Last updated
- 2024-07-23
Source: ClinicalTrials.gov record NCT06515977. Inclusion in this directory is not an endorsement.